Table 2 Use of allopurinol in 145 patients who had consulted a doctor about gout
Current allopurinol use
YesNop Value
n (%)44 (30%)101 (70%)
Age (years), median (range)65 (42 to 79)66 (24 to 83)0.670
Male gender, n (%)42 (96%)79 (78%)0.010
Disease duration (years), median (range)16 (0 to 44)9 (0 to 50)0.011
Delay to starting allopurinol (months), median (range)48 (0 to 312)
Length of treatment (months), median (range)120 (1 to 480)
Self-reported adherence <90%7 (15%)
Serum urate (μmol/l), mean (SD)318 (66)434 (101)<0.001
Serum urate >360 μmol/l, n (%)10 (23%)75 (75%)<0.001
At least 1 attack in preceding year14 (32%)57 (57%)0.005